Barely Significant
← all excerpts

Dapagliflozin: an evidence-based review of its potential in the treatment of type-2 diabetes.

Core Evid · 2012 · PMC3373192 · PMID 22701099

1
hedged sentence
closest p
boldest claim

The sentences

27 The study by Ferrannini et al 21 was an exception, in that the mean body weight reductions did not reach statistical significance, although they were higher than with the placebo at all doses.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.